Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia

BACKGROUND: The present study investigated factors associated with therapeutic benefits after autologous bone marrow cell (BMC) therapy in patients with “no-option” critical limb ischemia (CLI). METHODS AND RESULTS: Sixty-two patients with advanced CLI (Rutherford category 5 or 6) not eligible for r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cell Res Ther
Autors principals: Madaric, Juraj, Klepanec, Andrej, Valachovicova, Martina, Mistrik, Martin, Bucova, Maria, Olejarova, Ingrid, Necpal, Roman, Madaricova, Terezia, Paulis, Ludovit, Vulev, Ivan
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4987968/
https://ncbi.nlm.nih.gov/pubmed/27530339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-016-0379-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars